ZB
ALNY icon

Zions Bancorporation’s Alnylam Pharmaceuticals ALNY Stock Holding History

Zions Bancorporation’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$158K Buy
672
+80
+14% +$21K 0.01% 337
2024
Q3 		$163K Buy
592
+572
+2,860% +$149K 0.01% 339
2024
Q2 		$4.86K Buy
20
+6
+43% +$947 ﹤0.01% 758
2024
Q1 		$2.09K Sell
14
-5
-26% -$834 ﹤0.01% 828
2023
Q4 		$3.64K Sell
19
-5
-21% -$852 ﹤0.01% 777
2023
Q3 		$4.25K Hold
24
– – ﹤0.01% 746
2023
Q2 		$4.56K Buy
24
+10
+71% +$1.98K ﹤0.01% 740
2023
Q1 		$2.8K Sell
14
-7
-33% -$1.47K ﹤0.01% 796
2022
Q4 		$4.99K Sell
21
-1
-5% -$213 ﹤0.01% 855
2022
Q3 		$4K Buy
22
+3
+16% +$572 ﹤0.01% 796
2022
Q2 		$3K Buy
+19
New +$2.69K ﹤0.01% 917
2021
Q1 		– Sell
-32
Closed -$4K – 952
2020
Q4 		$4K Hold
32
– – ﹤0.01% 804
2020
Q3 		$5K Hold
32
– – ﹤0.01% 802
2020
Q2 		$5K Hold
32
– – ﹤0.01% 734
2020
Q1 		$3K Hold
32
– – ﹤0.01% 751
2019
Q4 		$4K Hold
32
– – ﹤0.01% 809
2019
Q3 		$3K Buy
+32
New +$2.53K ﹤0.01% 828
2019
Q2 		– Sell
-45
Closed -$4K – 920
2019
Q1 		$4K Buy
45
+32
+246% +$2.68K ﹤0.01% 780
2018
Q4 		$1K Buy
+13
New +$1K ﹤0.01% 437
2016
Q4 		– Sell
-19
Closed -$1K – 843
2016
Q3 		$1K Hold
19
– – ﹤0.01% 770
2016
Q2 		$1K Buy
+19
New +$1.2K ﹤0.01% 753

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Zions Bancorporation's ALNY Position: Q4 2024 in Review

Zions Bancorporation increased its Alnylam Pharmaceuticals (ALNY) stake by 14% in Q4 2024, buying an estimated $21K and bringing the position to 672 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #337.

Zions Bancorporation first reported a position in ALNY in Q2 2016 and has held it in 21 quarters since. The position peaked at $163K in Q3 2024. 594 funds tracked by Wall St. Rank hold ALNY as of Q4 2024.

  • Zions Bancorporation held 672 shares of Alnylam Pharmaceuticals worth $158K as of Q4 2024.
  • Zions Bancorporation bought 80 Alnylam Pharmaceuticals shares in Q4 2024, an estimated $21K.
  • Alnylam Pharmaceuticals made up 0.01% of Zions Bancorporation's portfolio in Q4 2024, its #337 holding.
  • Zions Bancorporation first reported a position in Alnylam Pharmaceuticals in Q2 2016 and has held it in 21 quarters since.
  • Zions Bancorporation's Alnylam Pharmaceuticals position peaked at $163K in Q3 2024.
  • 594 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.